Sign in

CIK 0000748592

  • Non-accelerated filer
  • Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
311103425
Phone
+1 617-798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 3 Insider Initial Statement of Ownership
  2. 4 Shares withheld for taxes Vice President of Finance gave up 179 shares (to pay taxes)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Director bought 261,756 shares at $3.28 ($858,560)
  7. 4 Open-market buy Director bought 283,286 shares at $3.28 ($929,178)
  8. 4 Open-market buy 10% owner bought 335,920 shares at $3.28 ($1,101,818)
  9. 4 Exercise or conversion Chief Medical Officer acquired 20,163 shares (option exercise)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Shares withheld for taxes Chief Scientific Officer gave up 6,077 shares (to pay taxes)
  16. 4 Shares withheld for taxes Vice President of Finance gave up 3,586 shares (to pay taxes)
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 3 of 29 · 572 filings